The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.
The DCP Community Oncology and Prevention Trials Research Group administers this program.
On This Page
- All Heading 2s will automatically be pulled in to this list.
- Do not edit the content on this template.
About NCORP
The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.
Grantee Details
Clinical Trials
| Title Sort descending | Intervention | Sponsor | Status |
|---|---|---|---|
| A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study | Goal Setting, Interview, Media Intervention, Medical Device Usage and Evaluation, Questionnaire Administration, Reward, Text Message-Based Navigation Intervention | Children's Oncology Group | Active, not recruiting |
| A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma | Biospecimen Collection, Electronic Health Record Review, Magnetic Resonance Imaging, Survey Administration | Children's Oncology Group | Recruiting |
| A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home | Biospecimen Collection, Compliance Monitoring, Health Promotion and Education, Informational Intervention, Media Intervention, Medical Device Usage and Evaluation, Mercaptopurine, Questionnaire Administration, Telephone-Based Intervention, Training and Education | Children's Oncology Group | Active, not recruiting |
| A Study of MiRNA 371 in Patients with Germ Cell Tumors | Biomarker Analysis, Blood Product Collection | SWOG Cancer Research Network | Active, not recruiting |
| A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients | Biospecimen Collection, Letermovir | Children's Oncology Group | Active, not recruiting |
| A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer | Bilateral Salpingectomy, Bilateral Salpingectomy with Oophorectomy, Biospecimen Collection, Magnetic Resonance Imaging, Quality-of-Life Assessment, Questionnaire Administration, Transvaginal Ultrasound, Ultrasound Imaging | NRG Oncology | Recruiting |
| A Study to Establish a New Onset Hyperglycemia and Diabetes Cohort | Fred Hutchinson Cancer Center | Active, not recruiting | |
| A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) | anastrozole | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
| A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia | Biospecimen Collection, Clinical Evaluation, Neurocognitive Assessment, Questionnaire Administration, Survey Administration | Children's Oncology Group | Recruiting |
| A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor | Biospecimen Collection, Cognitive Assessment, Magnetic Resonance Imaging, Memantine Hydrochloride, Placebo Administration, Questionnaire Administration | Children's Oncology Group | Active, not recruiting |
News and Events
NCORP recognizes Kathleen Yost Butler, Kamara Mertz-Rivera, Jordan Vogelsberg with 2025 awards
Date Posted: September 12, 2025
Large-scale TMIST Breast Cancer Screening Trial Achieves Enrollment Goal
Date Posted: January 15, 2025
Prevention and Screening Drive Drop in Cancer Deaths
Date Posted: January 14, 2025
NCI-Funded Research at the 2024 San Antonio Breast Cancer Symposium December 10-13
Date Posted: November 25, 2024
NCORP-supported Research Shows Olanzapine May Reduce Chemotherapy-Induced Nausea
Date Posted: September 30, 2024